1060726-68-2

Upstream product

• 1060724-84-6 5-(4-bromobutoxy)pyrazolo[1,5-a]pyridine 
• 620-08-6 4-methoxypyridine 
• 99446-31-8 5-methoxy-pyrazolo[1,5-a]pyridine-3-carboxylic acid methyl ester 
• 1060725-77-0 5-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-a]pyridine-3-carbaldehyde 
• 156969-42-5 pyrazolo<1,5-a>pyridin-5-ol 
• 1060725-03-2 5-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-a]pyridine 
• 1060726-57-9 (s-trans) 5-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy]pyrazolo[1,5-a]pyridine-3-carbaldehyde oxime 
• 1060726-55-7 (E)-5-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-a]pyridine-3-carbaldehyde oxime 

Downstream Products

• 1060727-90-3 3-aminomethyl-5-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]pyrazolo[1,5-a]pyridine 

Relevant academic research and scientific papers

Functionally selective dopamine D2, D3 receptor partial agonists

Dopamine D2 receptor-promoted activation of Gαo over Gαi may increase synaptic plasticity and thereby might improve negative symptoms of schizophrenia. Heterocyclic dopamine surrogates comprising a pyrazolo[1,5-a]pyridine

Indolizines and aza-analog derivatives thereof as CNS active compounds

Presently disclosed are indolicine-based compounds of the general formula which have medical utility, for example as antipsychotics.